BriaCell Therapeutics BCTX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 7.11 | 100.71 | -2.23 | -7,531 | -7 | |
| 2025Q3 | 11.00 | 101.08 | -4.35 | -8,323 | -8 | |
| 2025Q2 | 29.40 | 104.80 | 4.81 | -8,554 | -8 | |
| 2025Q1 | 36.50 | 102.86 | -12.65 | -6,328 | -6 | |
| 2024Q4 | 84.75 | 112.47 | -21.68 | -7,169 | -6 | |
| 2024Q3 | 186.00 | 89.49 | -32.67 | -5,153 | -6 | |
| 2024Q2 | 171.00 | 624.92 | -10.08 | -5,768 | -1 | |
| 2024Q1 | 429.00 | 16.80 | -9,230 | 2 | ||
| 2023Q4 | 877.50 | 40.46 | 24.60 | -9,829 | -11 | |
| 2023Q3 | 937.50 | -142.69 | -75.00 | -8,503 | 6 | |
| 2023Q2 | 963.00 | -22.50 | -7,706 | -2 | ||
| 2023Q1 | 1117.50 | -46.50 | -5,677 | -5 | ||
| 2022Q4 | 655.50 | -115.49 | -4,486 | -12 | ||
| 2022Q3 | 843.00 | 488.52 | -10.50 | -5,403 | -1 | |
| 2022Q2 | 865.50 | 14.34 | -5,907 | -17 | ||
| 2022Q1 | 1521.00 | -9.75 | 2,302 | 2 | ||
| 2021Q4 | 1242.00 | 10.65 | 2,199 | 2 | ||
| 2021Q3 | 1215.00 | -2.40 | -2,285 | -2 | ||
| 2021Q2 | 799.50 | 59.63 | -1,589 | -3 | ||
| 2021Q1 | 579.00 | 9.41 | -4,810 | 3 |